Fresh (PHresh). Less than 1-2 years since publication

Pulmonary hypertension in infancy: a reversible cause

Cassandra Campbell, Kawaljeet Singh, Mark Weems, Panjit PhilipUniversity of Tennessee Health Science Center.United States British Medical Journals Case ReportsBMJ Case Rep 2025; 18:DOI: 10.1136/bcr-2024-263731 AbstractA term, healthy infant presented with respiratory distress and severe pulmonary hypertension (PH). With an unclear aetiology and the intent to decrease right ventricular afterload, pulmonary vasodilators were initiated. Follow-up imaging revealed […]

Pulmonary hypertension in infancy: a reversible cause Read More »

His-Bundle Pacing for Pulmonary Hypertension With Bradycardia in Congenital Heart Disease: A Case Report

Daiji Takeuchi, Takashi Fujii, Tomomi Nishimura, Kei Inai, Morio ShodaTokyo Women’s Medical University.Japan Pacing and Clinical ElectrophysiologyPacing Clin Electrophysiol 2024; DOI: 10.1111/pace.15098 AbstractBradycardia, atrial tachyarrhythmia, heart failure, residual shunts, and pulmonary hypertension (PH) are significant problems after congenital heart disease surgery. We performed His-bundle pacing (HBP) for drug-resistant PH with bradycardia in a woman post-total anomalous

His-Bundle Pacing for Pulmonary Hypertension With Bradycardia in Congenital Heart Disease: A Case Report Read More »

Late-Onset Noninfectious Pulmonary Complications after Hematopoietic Stem Cell Transplantation

Andrew C. Harris, Kimia Ganjaei, Camila Vilela, Alexander GeyerMemorial Sloan Kettering Cancer Center. Lenox Hill Hospital and Northwell Health. United States Transplantation and Cellular TherapyTransplant Cell Ther 2024; 30: DOI: 10.1016/j.jtct.2024.05.022 AbstractAbstract Not Available CategoryClass V. Pulmonary Hypertension Associated with Hematological, Systemic, Metabolic and Other DisordersReview Articles Concerning Pulmonary Vascular Disease Age Focus: Pediatric Pulmonary Vascular

Late-Onset Noninfectious Pulmonary Complications after Hematopoietic Stem Cell Transplantation Read More »

Classical dendritic cells contribute to hypoxia-induced pulmonary hypertension

Claudia Mickael, Linda A. Sanders, Michael H. Lee, Rahul Kumar, Dara Fonseca- Balladares, Aneta Gandjeva, Kelly Cautivo-Reyes, Biruk Kassa, Sushil Kumar, David Irwin, Delaney Swindle, Tzu Phang, Robert S. Stearman, Ari B. Molofsky, Amy S. MxKee, Kurt R. Stenmark, Brian B. Graham, Rubin M. TuderUniversity of Colorado. University of California San Francisco. Zuckerberg San Francisco

Classical dendritic cells contribute to hypoxia-induced pulmonary hypertension Read More »

Double-Barrel Stent With Side-Cell Crush Technique for the Management of Complex Pulmonary Vein Stenosis

Conor P. O’Halloran, Matthew Cornicelli, Amanda Hauck, Paul TannousAnn & Robert H. Lurie Children’s Hospital of Chicago and Northwestern University Feinberg School of Medicine.United States Journal of the Society for Cardiovascular Angiography and InterventionsJ Soc Cardiovasc Angiogr Interv 2024; 3: DOI: 10.1016/j.jscai.2024.101938 AbstractAbstract Not Available CategorySegmental Pulmonary Venous Disease. Without a Focus on Pulmonary HypertensionSurgical and

Double-Barrel Stent With Side-Cell Crush Technique for the Management of Complex Pulmonary Vein Stenosis Read More »

Pharmacological Gq inhibition induces strong pulmonary vasorelaxation and reverses pulmonary hypertension

Alexander Seidinger, Richard Roberts, Yan Bai, Marion Müller, Eva Pfeil, Michaela Matthey, Sarah Rieck, Judith Alenfelder, Gabriele M. KUonig, Alexander Pfeifer, Evi Kostenis, Anna Klinke, Bernd K. Fleischmann, Daniela WenzelUniversity Hospital of the Ruhr University of Bochum and Ruhr University of Bochum. University Hospital of Nottingham. Massachusetts General Hospital and Harvard Medical School. University of

Pharmacological Gq inhibition induces strong pulmonary vasorelaxation and reverses pulmonary hypertension Read More »

Fibroblasts in Pulmonary Hypertension: Roles and Molecular Mechanisms

Hui Zhang, Min Li, Cheng-Jun Hu, Kurt R. StenmarkUniversity of Colorado School of Medicine and School of Dental Medicine.United States CellsCells 2024; 13: DOI: 10.3390/cells13110914 AbstractFibroblasts, among the most prevalent and widely distributed cell types in the human body, play a crucial role in defining tissue structure. They do this by depositing and remodeling extracellular matrixes

Fibroblasts in Pulmonary Hypertension: Roles and Molecular Mechanisms Read More »

Cardiorenal Syndrome in Right Heart Failure Due to Pulmonary Arterial Hypertension-The Right Ventricle as a Therapeutic Target to Improve Renal Function

Kenzo Ichimura, Adam Gross, Roy O. Mathew, Loay Salman, Sushma Reddy, Edda Spiekerkoetter, Mandeep S. SidhuStanford University. Albany Medical College. Loma Linda VA Health Care System. United States Cardiovascular Drugs and TherapyCardiovasc Drugs Ther 2024; DOI: 10.1007/s10557-024-07588-8 AbstractCardiorenal syndrome (CRS) due to right ventricular (RV) failure is a disease entity emerging as a key indicator of

Cardiorenal Syndrome in Right Heart Failure Due to Pulmonary Arterial Hypertension-The Right Ventricle as a Therapeutic Target to Improve Renal Function Read More »

Resistin predicts disease severity and survival in patients with pulmonary arterial hypertension

Li Gao, John Skinner, Tanmay Nath, Qing Lin, Megan Griffiths, Rachel L. Damico, Michael W. Pauciulo, William Nichols, Paul M. Hassoun, Allen Everett, Roger A. JohnsJohns Hopkins University School of Medicine. University of Texas Southwestern Medical Center. Cincinnati Children’s Hospital Medical Center and University of Cincinnati. United States Respiratory ResearchRespir Res 2024; 25: DOI: 10.1186/s12931-024-02861-8 AbstractBackground: Abnormal

Resistin predicts disease severity and survival in patients with pulmonary arterial hypertension Read More »

Scroll to Top